GLP-1 receptor agonists show promise in treating hidradenitis suppurativa, offering significant symptom relief and improved ...

A new study finds Medicare beneficiaries are facing higher deductibles and cost-sharing requirements following changes ...

A lack of training and vague, overlapping symptoms can be attributed to more than three-quarters of autoimmune patients being ...

This recent study underscores the fact that biomarkers serve not merely as statistical instruments but as insights into ...

Prefilled syringes of Imuldosa now have the lowest wholesaler acquisition cost among all branded ustekinumab biosimilars, ...

An expert discusses how phototherapy requires 2 to 3 sessions per week in specialized light booths or home units, is particularly useful for vitiligo covering more than 10% body surface area, and can ...

In an analysis from Trilliant Health of 11 inpatient and outpatient procedures, Aetna and UnitedHealthcare had huge variations in rates across the country, across states, and even at the same facility ...

Tonmya is the first new fibromyalgia treatment approved by the FDA in more than 15 years, providing symptom relief for at ...

Wegovy is the first GLP-1 drug approved to treat adults with metabolic dysfunction-associated steatohepatitis (MASH). An ...

Joshua Fredell, Pharm.D., senior vice president at CVS Caremark, says innovation in PBMs comes from simplifying pricing, offering flexible benefit designs, and using technology to create a smoother ...

We’ll be back on Monday morning with more fresh content!

To help Medicare plans better manage members with high drug expenses, Prime Therapeutics has launched an AI-driven tool to ...